Clinical trial · Interventional
Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment
Integration of Palliative Care for Cancer Patients on Phase I Trials
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot randomized clinical trial studies palliative care intervention in improving quality of life, psychological distress, and communication in patients with solid tumors receiving treatment on phase I trials. Cancer patients experience many symptoms related to treatment and the cancer itself that can be distressing and impact quality of life. Palliative care focuses on managing these symptoms and may help patients with solid tumors live more comfortably.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| palliative care | Other | — | UNRESOLVED |
| quality-of-life assessment | Procedure | — | UNRESOLVED |
| survey administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm I (early PCI)
- description
- Patients receive part I of the PCI comprising quantitative surveys, comprehensive palliative care assessment by the Research Nurses, and goals of care discussions beginning prior to administration of the first dose of phase I treatment. Patients then receive part II of the PCI comprising recommendations from the interdisciplinary team, patient educational sessions, and supportive care referrals following the first dose of phase I treatment and is completed within one month of the first treatment.
- interventionNames
- Other: palliative care
- Procedure: quality-of-life assessment
- Other: survey administration
- type
- EXPERIMENTAL
- label
- Arm II (delayed PCI)
- description
- Patients receive usual care until 12 weeks post-treatment initiation. Patients then receive both part I and II of the PCI.
- interventionNames
- Other: palliative care
- Procedure: quality-of-life assessment
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Patients diagnosed with solid tumors who are eligible for participation in Phase I clinical trials of investigational cancer therapies * Patients who have signed an informed consent for participation in Phase I clinical trials * Able to read or understand English-this is included because the intervention and study materials (including outcome measures) are only in English * Ability to read and/or understand the study protocol requirements, and provide written informed consent Exclusion Criteria: * Patients diagnosed with hematologic (as a population distinct from solid tumors and different trials) cancers.
References
Publications (0)
Data not yet available